References
- Vincent JL, Bihari DJ, Suter PM, Bruining HA, White J, Nicolas-Chanoin MH, et al. The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee. JAMA 1995; 274: 639–44
- National Nosocomial Infections Surveillance (NNIS). System Report, data summary from January 1992 through June 2003, issued August 2003. Am J Infect Control 2003; 31: 481–98
- Kollef MH, Sherman G, Ward S, Fraser VJ. Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. Chest 1999; 115: 462–74
- Leroy O, Meybeck A, D'Escrivan T, Devos P, Kipnis E, Georges H. Impact of adequacy of initial antimicrobial therapy on the prognosis of patients with ventilator-associated pneumonia. Intensive Care Med 2003; 29: 2170–3
- Dupont H, Mentec H, Sollet JP, Bleichner G. Impact of appropriateness of initial antibiotic therapy on the outcome of ventilator-associated pneumonia. Intensive Care Med 2001; 27: 355–62
- Iregui M, Ward S, Sherman G, Fraser VJ, Kollef MH. Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator-associated pneumonia. Chest 2002; 122: 262–8
- Hoffken G, Niederman MS. Nosocomial pneumonia: the importance of a de-escalating strategy for antibiotic treatment of pneumonia in the ICU. Chest 2002; 122: 2183–96
- Kollef MH, Fraser VJ. Antibiotic resistance in the intensive care unit. Ann Intern Med 2001; 134: 298–314
- McManus P, Hammond ML, Whicker SD, Primrose JG, Mant A, Fairall SR. Antibiotic use in the Australian community, 1990–1995. Med J Aust 1997; 167: 124–7
- Cars O, Molstad S, Melander A. Variation in antibiotic use in the European Union. Lancet 2001; 357: 1851–3
- Hanberger H, Diekema D, Fluit A, Jones R, Struelens M, Spencer R, et al. Surveillance of antibiotic resistance in European ICUs. J Hosp Infect 2001; 48: 161–76
- CDC. Pneumonia flow diagram. CDC (cited. 2005, Aug 1). Available from: URL:, http://www.cdc.gov/ncidod/hip/NNIS/members/pneumonia/Final/AnyPatientFlowDiagpdframVer2_2
- Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med 1985; 13: 818–29
- Rello J, Sa-Borges M, Correa H, Leal SR, Baraibar J. Variations in aetiology of ventilator-associated pneumonia across 4 treatment sites: implications for antimicrobial prescribing practices. Am J Respir Crit Care Med 1999; 160: 608–13
- ATC. Index of DDD. Oslo: WHO Collaborating Centre for Drug Statistics Methodology. 1999.
- Schonheyder HC. Clinical microbiological study of sputum and aspirates from larynx or trachea. An evaluation of exact criteria for assessment by direct microscopy. Ugeskr Laeger 1994; 156: 5703–7
- Heineman HS, Chawla JK, Lopton WM. Misinformation from sputum cultures without microscopic examination. J Clin Microbiol 1977; 6: 518–27
- Murray PR, Washington JA. Microscopic and bacteriological analysis of expectorated sputum. Mayo Clin Proc 1975; 50: 339–44
- Geckler RW, Gremillion DH, McAllister CK, Ellenbogen C. Microscopic and bacteriological comparison of paired sputa and transtracheal aspirates. J Clin Microbiol 1977; 6: 396–9
- Chastre J, Fagon JY. Ventilator-associated pneumonia. Am J Respir Crit Care Med 2002; 165: 867–903
- Lesens O, Methlin C, Hansmann Y, Remy V, Martinot M, Bergin C, et al. Role of comorbidity in mortality related to Staphylococcus aureus bacteraemia: a prospective study using the Charlson weighted index of comorbidity. Infect Control Hosp Epidemiol 2003; 24: 890–6
- Niederman MS. The clinical diagnosis of ventilator-associated pneumonia. Respir Care 2005; 50: 788–96
- Neuhauser MM, Weinstein RA, Rydman R, Danziger LH, Karam G, Quinn JP. Antibiotic resistance among Gram-negative bacilli in US intensive care units: implications for fluoroquinolone use. JAMA 2003; 289: 885–8
- Moller JK. Antimicrobial usage and microbial resistance in a university hospital during a 7-y period. J Antimicrob Chemother 1989; 24: 983–92
- Seppala H, Klaukka T, Vuopio-Varkila J, Muotiala A, Helenius H, Lager K, et al. The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. Finnish Study Group for Antimicrobial Resistance. N Engl J Med 1997; 337: 441–6